ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2267

Ocular and Systemic Features in 262 Patients with Systemic Sarcoidosis and Its Correlation with Iwos Criteria

Belén Atienza-Mateo1, José Luis Martín-Varillas1, Rosalía Demetrio-Pablo2, Vanesa Calvo-Río3, Diana Prieto Peña3, Monica Calderón Goercke3, Javier Rueda-Gotor1, Enar Pons1, Miguel Angel González-Gay2 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ocular involvement, sarcoidosis, systemic illness and uveitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sarcoidosis is a multisystemic inflammatory disease of unknown origin characterized by non-caseating epitheliod granulomas that can affect any organ system. The three most frequency affected organs are lung, skin and eyes. Ocular involvement is the presenting symptom in approximately 20-30% and can involve any part of the eye and its anexal tissues. Sarcoidosis may cause uveitis, conjunctivitis, episcleritis/scleritis, optical nerve disease and orbital inflammation. The aim of this study was to analyze the prevalence of ocular involvement in systemic sarcoidosis in the population of Cantabria (Spain), the clinical patterns and their correlation with the IWOS criteria.

Methods: Retrospective study of patients admitted to a single reference University Hospital between 2004 and 2017 with diagnosis of sarcoidosis. Clinical findings, demographics features, anatomic location and IWOS intraocular signs were recorded. We also collected serum angiotensin converting enzyme (ACE), liver enzyme test, chest radiography, chest computed tomography scan (CT), treatment and biopsy if it was performed.

Results: We included 262 patients with diagnosis of sarcoidosis. Most of the cases were women (59%) with a median age of 44 years. The most affected organ was lung (79%), followed by skin (25%) and eye (12.2%). Thirty-two patients had ocular symptoms due to sarcoid disease and 29 of them had uveitis. There were 27 patients (84.4%) who met one of the 4 IWOS ocular sarcoidosis diagnostic categories: 15 with definite (46.9%), 9 presumed (28.1%) and 3 with posible (9.4%) sarcoidosis. Five patients did not meet IWOS criteria. The most common ocular signs were bilaterality (55.2%), snowballs or strings of pearls (51.7%), mutton-fat KPs (31%), multiple chorioretinal peripheral lesions (20.7%) and periphlebitis (13.8%). ACE increase was observed in 23% of patients with ocular sarcoidosis with a median value of 75.9. Ninety three percent of patients received oral corticosteriods, 17 a conventional inmunosupresor and 5 a biological treatment.

Conclusion: The eye is the third organ of sarcoidosis involvement. Although there is no gold standar for diagnosing ocular sarcoidosis yet, IWOS signs can help clinicians suspect it. However, there seem to be some limitations.


Disclosure: B. Atienza-Mateo, None; J. L. Martín-Varillas, None; R. Demetrio-Pablo, None; V. Calvo-Río, None; D. Prieto Peña, None; M. Calderón Goercke, None; J. Rueda-Gotor, None; E. Pons, None; M. A. González-Gay, None; R. Blanco, None.

To cite this abstract in AMA style:

Atienza-Mateo B, Martín-Varillas JL, Demetrio-Pablo R, Calvo-Río V, Prieto Peña D, Calderón Goercke M, Rueda-Gotor J, Pons E, González-Gay MA, Blanco R. Ocular and Systemic Features in 262 Patients with Systemic Sarcoidosis and Its Correlation with Iwos Criteria [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/ocular-and-systemic-features-in-262-patients-with-systemic-sarcoidosis-and-its-correlation-with-iwos-criteria/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ocular-and-systemic-features-in-262-patients-with-systemic-sarcoidosis-and-its-correlation-with-iwos-criteria/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology